Comparison of overall survival after neoadjuvant and adjuvant chemotherapy in patients with early breast cancer with immediate breast reconstruction after mastectomy: A retrospective, matched case-control study

被引:2
|
作者
Liu, Chia-Hua [1 ]
Yang, Jie-Ru [1 ]
Tsai, I-Chen [1 ,2 ]
Hsu, Chiann-Yi [3 ]
Yean, Lum Chih [1 ]
Hung, Chih-Chiang [1 ,4 ,5 ]
机构
[1] Taichung Vet Gen Hosp, Dept Surg, Div Breast Surg, Taichung 40705, Taiwan
[2] China Med Univ, Grad Inst Biomed Sci, Coll Med, Taichung 40402, Taiwan
[3] Taichung Vet Gen Hosp, Dept Med Res, Biostat Task Force, Taichung 40705, Taiwan
[4] Hung Kuang Univ, Coll Human Sci & Social Innovat, Dept Appl Cosmetol, Taichung 43302, Taiwan
[5] Taichung Vet Gen Hosp, Dept Surg, Div Breast Surg, 1650 Taiwan Blvd Sect 4, Taichung 40705, Taiwan
关键词
breast cancer; breast reconstruction; chemotherapy; neoadjuvant; adjuvant; overall survival; IMPACT; WOMEN; COMPLICATIONS; DEPRESSION; PROGNOSIS; OUTCOMES; THERAPY; COHORT;
D O I
10.3892/ol.2022.13557
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Immediate breast reconstruction after mastectomy combined with chemotherapy is the preferred option for patients with early-stage breast cancer who require both superior clinical and aesthetic outcomes. The present study aimed to determine the survival benefits of neoadjuvant and adjuvant chemotherapy for patients with early-stage breast cancer who have undergone immediate breast reconstruction after mastectomy in Taiwan. The present study compared overall survival (OS) following neoadjuvant or adjuvant chemotherapy in 139 patients with early-stage breast cancer who underwent immediate breast reconstruction after mastectomy. Patient data were used retrospectively as an unmatched cohort. Next, 37 neoadjuvant cases were matched with 37 adjuvant controls through 1:1 age-, clinical stage-, and molecular subtype-matching. OS differences between the cases and controls were determined using Kaplan-Meier survival curve analyses. Here, 77.7 and 81.1% of the unmatched and matched cohort patients were aged <50 years, respectively. Of the matched neoadjuvant cases, 10 (15.6%) reached pathologic complete response after neoadjuvant chemotherapy, whereas 5 (13.5%) neoadjuvant cases succumbed during the study period. The neoadjuvant matched cases demonstrated a significantly poor OS with their adjuvant matched controls (P=0.044); nevertheless, the stratification analysis results demonstrated that the survival differences between the neoadjuvant and the adjuvant controls decreased after matching. Targeted therapy demonstrated the same OS benefits for both the neoadjuvant matched cases and adjuvant matched controls (P=1.000). This study provided matched case-control evidence for the feasibility of neoadjuvant chemotherapy combined with targeted therapy for patients with early-stage breast cancer with immediate breast reconstruction after mastectomy in a Taiwanese female population.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Oncologic Outcomes after Immediate Breast Reconstruction Following Total Mastectomy in Patients with Breast Cancer: A Matched Case-Control Study
    Ryu, Jai Min
    Paik, Hyun-June
    Park, Sungmin
    Yi, Ha Woo
    Nam, Seok Jin
    Kim, Seok Won
    Lee, Se Kyung
    Yu, Jonghan
    Bae, Soo Youn
    Lee, Jeong Eon
    [J]. JOURNAL OF BREAST CANCER, 2017, 20 (01) : 74 - 81
  • [2] Oncologic outcomes after immediate breast reconstruction following total mastectomy in patients with breast cancer: a matched case-control study
    Ryu, J. M.
    Kim, I.
    Nam, S. J.
    Kim, S. W.
    Lee, S. K.
    Bae, S. Y.
    Yu, J.
    Lee, J. E.
    [J]. BREAST, 2017, 32 : S103 - S104
  • [3] Survival outcomes of autologous breast reconstruction after mastectomy: A matched case-control study
    Wu, Shang
    Ma, Xindi
    Zhang, Xiangmei
    Yang, Chao
    Wang, Yubin
    Liu, Yunjiang
    [J]. FRONTIERS IN ONCOLOGY, 2023, 12
  • [4] Early Rehabilitation after Total Mastectomy and Immediate Reconstruction with Tissue Expander Insertion in Breast Cancer Patients: A Retrospective Case-control Study
    Kim, Kyou Hyun
    Yeo, Seung Mi
    Cheong, In Yae
    Kim, Yoon
    Jeon, Byung Joon
    Hwang, Ji Hye
    [J]. JOURNAL OF BREAST CANCER, 2019, 22 (03) : 472 - 483
  • [5] Concurrent adjuvant chemotherapy and immediate breast reconstruction with skin expanders after mastectomy for breast cancer
    Orazio Caffo
    Daniela Cazzolli
    Alberto Scalet
    Bruno Zani
    Gianni Ambrosini
    Maurizio Amichetti
    Daniele Bernardi
    Sonia Brugnara
    Gianni Ciaghi
    Antonio Lucenti
    Ninoo Natale
    Silvio Agugiaro
    Claudio Eccher
    Enzo Galligioni
    [J]. Breast Cancer Research and Treatment, 2000, 60 : 267 - 275
  • [6] Concurrent adjuvant chemotherapy and immediate breast reconstruction with skin expanders after mastectomy for breast cancer
    Caffo, O
    Cazzolli, D
    Scalet, A
    Zani, B
    Ambrosini, G
    Amichetti, M
    Bernardi, D
    Brugnara, S
    Ciaghi, G
    Lucenti, A
    Natale, N
    Agugiaro, S
    Eccher, C
    Galligioni, E
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2000, 60 (03) : 267 - 275
  • [7] WOUND COMPLICATIONS IN PATIENTS RECEIVING ADJUVANT CHEMOTHERAPY AFTER MASTECTOMY AND IMMEDIATE BREAST RECONSTRUCTION FOR BREAST-CANCER
    FUREY, PC
    MACGILLIVRAY, DC
    CASTIGLIONE, CL
    ALLEN, L
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 1994, 55 (03) : 194 - 197
  • [8] Impact of immediate breast reconstruction after mastectomy on the outcome of patients receiving neoadjuvant chemotherapy
    Nogi, Hiroko
    Tomita, Shoichi
    Kamio, Makiko
    Shioya, Hisashi
    Toriumi, Yasuo
    Takeyama, Hiroshi
    [J]. CANCER RESEARCH, 2018, 78 (04)
  • [9] Does Immediate Breast Reconstruction after Mastectomy affect the Initiation of Adjuvant Chemotherapy?
    Lee, Jeonghui
    Lee, Se Kyung
    Kim, Sangmin
    Koo, Min Young
    Choi, Min-Young
    Bae, Soo Youn
    Cho, Dong Hui
    Kim, Jiyoung
    Jung, Seung Pil
    Choe, Jun-Ho
    Kim, Jung-Han
    Kim, Jee Soo
    Lee, Jeong Eon
    Yang, Jung-Hyun
    Nam, Seok Jin
    [J]. JOURNAL OF BREAST CANCER, 2011, 14 (04) : 322 - 327
  • [10] Immediate reconstruction after mastectomy for breast cancer does not prolong the time to starting adjuvant chemotherapy
    Allweis, TM
    Boisvert, ME
    Otero, SE
    Perry, DJ
    Dubin, NH
    Priebat, DA
    [J]. AMERICAN JOURNAL OF SURGERY, 2002, 183 (03): : 218 - 221